Literature DB >> 28229271

New PET/CT criterion for nodal staging in non-small cell lung cancer: measurement of the ratio of section area of standard uptake values ≥2.5/lymph node section area.

Yoshitaro Saito1, Kazuhiro Imai2, Koichi Ishiyama3, Hajime Saito1, Satoru Motoyama1, Yusuke Sato1, Hayato Konno1, Satoshi Fujishima1, Manabu Hashimoto3, Yoshihiro Minamiya1.   

Abstract

BACKGROUND: The aim of the present study was to use surgical and histological results to develop a simple noninvasive technique for improving nodal staging using preoperative PET/CT in patients with resectable non-small cell lung cancer (NSCLC).
METHODS: Preoperative PET/CT findings (163 patients) and pathological diagnoses after surgical resection were evaluated. Using PET/CT images, lymph node section area (SA), the maximum standardized uptake value (SUVmax), SA of SUV ≥2.5 and ≥3.0 were drawn freehand and measured using caliper software. Receiver operating characteristic (ROC) curves were then used to analyze those data.
RESULTS: Based on ROC analyses, the cut-off values for SA of SUV ≥2.5, SA of SUV ≥3.0, SUV ≥2.5 SA/node SA and SUV ≥3.0 SA/node SA for diagnosis of lymph node metastasis were 200 mm2, 30 mm2, 1.0 and 0.4. SUV ≥2.5 SA/node SA ≥1.0 had the highest negative predictive value, and the sensitivity, specificity, positive predictive value, negative predictive value and accuracy of nodal staging were 61.1, 73.4, 36.7, 88.2 and 70.9%.
CONCLUSIONS: When diagnosing nodal staging based a lymph node SUV ≥2.5 SA/node SA ratio of ≥1.0, it can be an effective criterion for use to determine surgical indications.

Entities:  

Keywords:  Computed tomography; Lung cancer; Lymph node; Metastasis; Positron-emission tomography

Mesh:

Year:  2017        PMID: 28229271     DOI: 10.1007/s11748-017-0756-2

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  37 in total

1.  Whole body 18F-2-deoxyglucose positron emission tomography to restage non-small cell lung cancer.

Authors:  S P Changlai; S C Tsai; M C Chou; Y J Ho; C H Kao
Journal:  Oncol Rep       Date:  2001 Mar-Apr       Impact factor: 3.906

2.  Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions.

Authors:  N C Gupta; G M Graeber; H A Bishop
Journal:  Chest       Date:  2000-03       Impact factor: 9.410

3.  Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer.

Authors:  Matthew J Schuchert; Brian L Pettiford; Samuel Keeley; Thomas A D'Amato; Arman Kilic; John Close; Arjun Pennathur; Ricardo Santos; Hiran C Fernando; James R Landreneau; James D Luketich; Rodney J Landreneau
Journal:  Ann Thorac Surg       Date:  2007-09       Impact factor: 4.330

4.  Clinical relevance of imaging proliferative activity in lung nodules.

Authors:  Andreas K Buck; Martin Hetzel; Holger Schirrmeister; Gisela Halter; Peter Möller; Clemens Kratochwil; Andreas Wahl; Gerhard Glatting; Felix M Mottaghy; Torsten Mattfeldt; Bernd Neumaier; Sven N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12-14       Impact factor: 9.236

5.  Longitudinal observation of [11C]4DST uptake in turpentine-induced inflammatory tissue.

Authors:  Jun Toyohara; Muneyuki Sakata; Keiichi Oda; Kenji Ishii; Kiichi Ishiwata
Journal:  Nucl Med Biol       Date:  2012-11-07       Impact factor: 2.408

6.  The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.

Authors:  Craig E Daniels; Val J Lowe; Marie-Christine Aubry; Mark S Allen; James R Jett
Journal:  Chest       Date:  2007-01       Impact factor: 9.410

7.  Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.

Authors:  Sung Shine Shim; Kyung Soo Lee; Byung-Tae Kim; Myung Jin Chung; Eun Jung Lee; Joungho Han; Joon Young Choi; O Jung Kwon; Young Mog Shim; Seonwoo Kim
Journal:  Radiology       Date:  2005-07-12       Impact factor: 11.105

8.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

Review 9.  Small peripheral lung adenocarcinoma: clinicopathological features and surgical treatment.

Authors:  Takayuki Fukui; Tetsuya Mitsudomi
Journal:  Surg Today       Date:  2010-02-24       Impact factor: 2.549

10.  Is 18F-3'-fluoro-3'-deoxy-L-thymidine useful for the staging and restaging of non-small cell lung cancer?

Authors:  David C P Cobben; Philip H Elsinga; Harald J Hoekstra; Albert J H Suurmeijer; Willem Vaalburg; Bram Maas; Pieter L Jager; Harry M J Groen
Journal:  J Nucl Med       Date:  2004-10       Impact factor: 10.057

View more
  1 in total

1.  New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB-III) lung cancer: The standard uptake values ratio of ipsilateral/contralateral hilar nodes.

Authors:  Komei Kameyama; Kazuhiro Imai; Koichi Ishiyama; Shinogu Takashima; Shoji Kuriyama; Maiko Atari; Yoshiaki Ishii; Akihito Kobayashi; Shugo Takahashi; Mirai Kobayashi; Yuzu Harata; Yusuke Sato; Satoru Motoyama; Manabu Hashimoto; Kyoko Nomura; Yoshihiro Minamiya
Journal:  Thorac Cancer       Date:  2022-01-20       Impact factor: 3.500

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.